PHIL Inter Pharma received the MA for the 1st product in Korea and K-GMP
2018/11/28

We are glad to announce that PHIL Inter Pharma has been accredited with Korean GMP by Korean FDA
and successfully received the MA(Marketing Authorization) for the 1st product, Ibuprofen 200 mg softgel capsule
in November, 2018.

At the same time, PHIL International obtained the license to import pharmaceutical products in Korea.

Following the 1st MA approval, other softgel products such as Dutasteride 0.5 mg, Choline alfoscerate 400 mg,
Omega-3-acid ethyl esters 90 1,000mg will be applied shortly.